The carnage in the biotech space in Q4 of last year was devastating to a lot of portfolios, and many of the stocks in the space became victims of aggressive...
Clovis Oncology Inc (NASDAQ:CLVS) Going Strong With The Clinical Developmental Programs
Boston, MA 08/11/2014 (wallstreetpr) – Clovis Oncology Inc (NASDAQ:CLVS) posted second quarter financial results and gave the necessary information on its clinical developmental programs for the year. It said that...
Before You Trade: Double Eagle Petroleum Co (NASDAQ:DBLE), Clovis Oncology Inc (NASDAQ:CLVS), Conatus Pharmaceuticals Inc (NASDAQ:CNAT)
Boston, MA 03/27/2014 (wallstreetpr) - The anticipated change of guard and name at Double Eagle Petroleum Co (NASDAQ:DBLE) seem to be taken positively among investors. Moreover, promises by the company...
Clovis Oncology Inc (NASDAQ:CLVS) announced its Preliminary results of ovarian cancer drug
Boston, MA 06/04/2013 (wallstreetpr) - The share prices of Clovis Oncology Inc (NASDAQ:CLVS) had surged by more than 100 percent owing to the successful preliminary testing results of its drug for...